These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34192331)

  • 1. Preparation and biological activities of anti-HER2 monoclonal antibodies with multibranched complex-type N-glycans.
    Takashima S; Kurogochi M; Tsukimura W; Mori M; Osumi K; Sugawara SI; Amano J; Mizuno M; Takada Y; Matsuda A
    Glycobiology; 2021 Nov; 31(10):1401-1414. PubMed ID: 34192331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
    Raju TS
    Curr Opin Immunol; 2008 Aug; 20(4):471-8. PubMed ID: 18606225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors.
    Blundell P; Pleass R
    Methods Mol Biol; 2019; 1904():417-421. PubMed ID: 30539483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals.
    Edri-Brami M; Sharoni H; Hayoun D; Skutelsky L; Nemirovsky A; Porgador A; Lichtenstein RG
    Exp Neurol; 2015 May; 267():95-106. PubMed ID: 25725350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies.
    Aoyama M; Hashii N; Tsukimura W; Osumi K; Harazono A; Tada M; Kiyoshi M; Matsuda A; Ishii-Watabe A
    MAbs; 2019 Jul; 11(5):826-836. PubMed ID: 30990348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of
    Zou G; Kosikova M; Kim SR; Kotian S; Wu WW; Shen R; Powers DN; Agarabi C; Xie H; Ju T
    J Biol Chem; 2018 Dec; 293(50):19277-19289. PubMed ID: 30315103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
    Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
    J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.
    Kurogochi M; Mori M; Osumi K; Tojino M; Sugawara S; Takashima S; Hirose Y; Tsukimura W; Mizuno M; Amano J; Matsuda A; Tomita M; Takayanagi A; Shoda S; Shirai T
    PLoS One; 2015; 10(7):e0132848. PubMed ID: 26200113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
    Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
    Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and biological activities of anti-HER2 monoclonal antibodies with fully core-fucosylated homogeneous bi-antennary complex-type glycans.
    Tsukimura W; Kurogochi M; Mori M; Osumi K; Matsuda A; Takegawa K; Furukawa K; Shirai T
    Biosci Biotechnol Biochem; 2017 Dec; 81(12):2353-2359. PubMed ID: 29090617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Preparation of a 66-IgG Library with Symmetric and Asymmetric Homogeneous Glycans and Their Functional Evaluation.
    Manabe S; Iwamoto S; Nagatoishi S; Hoshinoo A; Mitani A; Sumiyoshi W; Kinoshita T; Yamaguchi Y; Tsumoto K
    J Am Chem Soc; 2024 Aug; 146(33):23426-23436. PubMed ID: 39106493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Fc N-linked glycans on in vivo clearance of an immunoglobulin G1 antibody produced by NS0 cell line.
    Kim J; Luo H; White W; Rees W; Venkat R; Albarghouthi M
    MAbs; 2020; 12(1):1844928. PubMed ID: 33171078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An atomistic perspective on antibody-dependent cellular cytotoxicity quenching by core-fucosylation of IgG1 Fc N-glycans from enhanced sampling molecular dynamics.
    Harbison A; Fadda E
    Glycobiology; 2020 May; 30(6):407-414. PubMed ID: 31829411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody-dependent cellular cytotoxicity.
    Branstetter E; Duff RJ; Kuhns S; Padaki R
    FEBS Open Bio; 2021 Nov; 11(11):2943-2949. PubMed ID: 34355537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc glycan-modulated immunoglobulin G effector functions.
    Quast I; Lünemann JD
    J Clin Immunol; 2014 Jul; 34 Suppl 1():S51-5. PubMed ID: 24760108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
    Hodoniczky J; Zheng YZ; James DC
    Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of anti-inflammatory immunoglobulin G Fc proteins.
    Ahmed AA; Giddens J; Pincetic A; Lomino JV; Ravetch JV; Wang LX; Bjorkman PJ
    J Mol Biol; 2014 Sep; 426(18):3166-3179. PubMed ID: 25036289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of antibody effector functions through IgG Fc N-glycosylation.
    Quast I; Peschke B; Lünemann JD
    Cell Mol Life Sci; 2017 Mar; 74(5):837-847. PubMed ID: 27639381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant impact of single N-glycan residues on the biological activity of Fc-based antibody-like fragments.
    Jez J; Antes B; Castilho A; Kainer M; Wiederkum S; Grass J; Rüker F; Woisetschläger M; Steinkellner H
    J Biol Chem; 2012 Jul; 287(29):24313-9. PubMed ID: 22589538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation.
    Castilho A; Gruber C; Thader A; Oostenbrink C; Pechlaner M; Steinkellner H; Altmann F
    MAbs; 2015; 7(5):863-70. PubMed ID: 26067753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.